Centro de Imagem Diagnósticos S.A Market Cap ($65.75 Million)
Market Cap & Net Worth: Centro de Imagem Diagnósticos S.A (AALR3)
Centro de Imagem Diagnósticos S.A market cap. Centro de Imagem Diagnósticos S.A (SA:AALR3) has a market capitalization of $65.75 Million (R$335.11 Million) as of November 6, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #20598 globally and #194 in its home market, demonstrating a -19.12% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Centro de Imagem Diagnósticos S.A's stock price R$2.20 by its total outstanding shares 152321877 (152.32 Million). Also see Centro de Imagem Diagnósticos S.A (AALR3) cash conversion ratio for how efficiently the company converts equity into cash flow.
Centro de Imagem Diagnósticos S.A Market Cap History (2016–2026)
Centro de Imagem Diagnósticos S.A market cap history from 2016 to 2026. Data shows change from $433.46 Million to $65.75 Million (-19.35% CAGR). Check current stock price of Centro de Imagem Diagnósticos S.A for real-time trading data and today's change.
Centro de Imagem Diagnósticos S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Centro de Imagem Diagnósticos S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore AALR3 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.13x
Centro de Imagem Diagnósticos S.A's market cap is 0.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $433.46 Million | $951.47 Million | $14.79 Million | 0.46x | 29.30x |
| 2017 | $437.90 Million | $1.08 Billion | $6.65 Million | 0.41x | 65.83x |
| 2018 | $393.81 Million | $1.08 Billion | $40.09 Million | 0.37x | 9.82x |
| 2019 | $538.32 Million | $1.07 Billion | $41.30 Million | 0.50x | 13.03x |
| 2020 | $331.76 Million | $928.79 Million | -$97.42 Million | 0.36x | N/A |
| 2021 | $447.43 Million | $1.14 Billion | -$5.62 Million | 0.39x | N/A |
| 2022 | $645.59 Million | $1.09 Billion | -$227.81 Million | 0.60x | N/A |
| 2023 | $310.84 Million | $1.18 Billion | -$227.88 Million | 0.26x | N/A |
| 2024 | $255.54 Million | $1.22 Billion | -$129.12 Million | 0.21x | N/A |
| 2025 | $150.94 Million | $1.15 Billion | -$1.37 Billion | 0.13x | N/A |
Competitor Companies of AALR3 by Market Capitalization
Companies near Centro de Imagem Diagnósticos S.A in the global market cap rankings as of November 6, 2026. Also see Centro de Imagem Diagnósticos S.A asset portfolio for a full breakdown of the balance sheet.
Key companies related to Centro de Imagem Diagnósticos S.A by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #146 globally with a market cap of $159.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #478 globally with a market cap of $55.90 Billion USD ( CN¥382.02 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #510 globally with a market cap of $52.43 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $676.94 |
| #146 | Danaher Corporation | NYSE:DHR | $159.88 Billion | $226.34 |
| #478 | WuXi AppTec Co Ltd | SHG:603259 | $55.90 Billion | CN¥154.46 |
| #510 | Natera Inc | NASDAQ:NTRA | $52.43 Billion | $363.76 |
Market Capitalization of Centro de Imagem Diagnósticos S.A (2016–2026)
Market capitalization of Centro de Imagem Diagnósticos S.A from 2016 to today. Between 2016 and today, Centro de Imagem Diagnósticos S.A's market cap moved from $433.46 Million to $ 65.75 Million, with a yearly change of -19.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$65.75 Million | -56.44% |
| 2025 | R$150.94 Million | -40.94% |
| 2024 | R$255.54 Million | -17.79% |
| 2023 | R$310.84 Million | -51.85% |
| 2022 | R$645.59 Million | +44.29% |
| 2021 | R$447.43 Million | +34.86% |
| 2020 | R$331.76 Million | -38.37% |
| 2019 | R$538.32 Million | +36.69% |
| 2018 | R$393.81 Million | -10.07% |
| 2017 | R$437.90 Million | +1.02% |
| 2016 | R$433.46 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Centro de Imagem Diagnósticos S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $65.75 Million USD |
| MoneyControl | $65.75 Million USD |
| MarketWatch | $65.75 Million USD |
| marketcap.company | $65.75 Million USD |
| Reuters | $65.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Centro de Imagem Diagnósticos S.A
Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more